2013
DOI: 10.1016/j.jconrel.2013.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Use of optical imaging to progress novel therapeutics to the clinic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 142 publications
0
14
0
Order By: Relevance
“…An increasing number of studies have demonstrated the optical imaging as a modality for preclinical in vivo examination of tumor detection, growth, and response to different treatments 26 27 28 29 30 . Because of its efficiency, the clinical potential for the in vivo optical imaging is becoming apparent 31 32 . Compared to the previously reported models using cells single-labeled with luciferase 6 7 , our model demonstrates the advanced evaluation of tumor characterization using ex vivo optical imaging with fluorescence.…”
Section: Discussionmentioning
confidence: 99%
“…An increasing number of studies have demonstrated the optical imaging as a modality for preclinical in vivo examination of tumor detection, growth, and response to different treatments 26 27 28 29 30 . Because of its efficiency, the clinical potential for the in vivo optical imaging is becoming apparent 31 32 . Compared to the previously reported models using cells single-labeled with luciferase 6 7 , our model demonstrates the advanced evaluation of tumor characterization using ex vivo optical imaging with fluorescence.…”
Section: Discussionmentioning
confidence: 99%
“…Fluorescent dye-based guidance during surgical interventions is being recognised as an improvement in the accuracy of clinical care [1][2][3]. In clinical trials, fluorescence imaging has been used as a sole modality or in a bimodal/hybrid form, wherein it extends the field of nuclear medicine [4].…”
Section: Introductionmentioning
confidence: 99%
“…In the basic science and preclinical settings, these techniques have delivered tremendous advances in understanding disease biology (1). They also have considerable utility in noninvasive evaluation of efficacy for drug development (2,3). The capability of such technologies to detect pathologic molecular processes, particularly to identify malignancy, has been a major driving force in their development.…”
mentioning
confidence: 99%